CVMR Solutions

CVMR is a privately held technology and refining company that utilizes its proprietary Chemical Vapour Metal Refining (CVMR®) process to serve the life sciences and healthcare industries. The company specializes in the production of high-purity medical isotopes, most notably Actinium-225 and Scandium-47, which are essential for targeted alpha therapy and advanced diagnostic imaging in oncology. Beyond isotope production, CVMR develops specialized metal-based nanoparticles designed for targeted drug delivery systems and the enhancement of medical implants. Their unique gas-phase metallurgical technology allows for the creation of ultra-pure materials that are difficult to produce through conventional methods. Headquartered in Canada with significant operations in the United States, CVMR provides critical infrastructure and materials to the global radiopharmaceutical market.